News Focus
News Focus
Followers 2
Posts 660
Boards Moderated 0
Alias Born 10/30/2004

Re: DewDiligence post# 928

Wednesday, 02/07/2007 12:09:40 AM

Wednesday, February 07, 2007 12:09:40 AM

Post# of 2446
Re: Ivation Phase 2

"That SRDX will proceed to a self-funded phase-2 trial using triamcinolone suggests to me that the interest from prospective partners in using the I-vation device with their own drugs is modest. "

Dew, perhaps several parties are sincerely interested, yet Surmodics hasn't been able to secure what they consider a fair royalty rate for I-vation. Commencing a phase 2 trial with triamcinolone should increase the value of the device.

On a related note, SRDX has said they might secure a partner for funding the phase 2 with triamcinolone. This surprised me, because I worry that such a partnership could leverage SRDX into an exclusive license for the delivery platform. Perhaps giving an exclusive is simply the reality of the climate. Thoughts on this?

The obstacle to discovery is the illusion of knowledge.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent SRDX News